Joseph M. Giaconia

CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar.

S. Schwartz, M. Resnick, T. P. Pretlow, 1996, Cancer research.

CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma.

S. Schwartz, M. Resnick, T. P. Pretlow, 1994, Cancer research.

A new human prostate carcinoma cell line, 22Rv1

S. Schwartz, T. P. Pretlow, J. Rhim, 1999, In Vitro Cellular & Developmental Biology - Animal.